Encysive Pharmaceuticals, Inc. (NASDAQ:ENCY.DL)
CAPS Rating:
A global biopharmaceutical company that engages in the discovery, development and commercialization of novel, synthetic, small molecule compounds to address unmet medical needs.
RSS Headlines
Fool UK